🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Given the role of IL-17 in the development of entheseal-driven pathology, a...
Status
Unknown
Location
Chinese Academy of Medical Sciences & Peking Union Medical College
Start Date
2021-07-15
Trial ID
NCT04967950
Treatments Being Tested
Given the role of IL-17 in the development of entheseal-driven pathology, a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-11-02
Trial ID
NCT04488185
Treatments Being Tested
This is a randomized, double-blinded, controlled Phase I study of new proce...
Status
Active Not Recruiting
Location
Shanghai Jiaotong University School of Medicine
Start Date
2025-12-15
Trial ID
NCT07254325
Treatments Being Tested
This study will establish whether prolonged chronic dosing with secukinumab...
Status
Active Not Recruiting
Location
Novartis Investigative Site
Start Date
2023-03-28
Trial ID
NCT05622708
Treatments Being Tested
The purpose of this study is to assess secukinumab high dose (every 2 weeks...
Status
Completed
Location
Novartis Investigative Site
Start Date
2018-06-25
Trial ID
NCT03504852
Treatments Being Tested
This study is a multicenter, randomized, double-blind, parallel-arm, Phase ...
Status
Completed
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2022-10-26
Trial ID
NCT05377944
Treatments Being Tested
The aim of this study is to determine whether oral Chinese herbal medicine ...
Status
Unknown
Location
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start Date
2020-06-04
Trial ID
NCT04414605
Treatments Being Tested
This extension study will assess the safety and efficacy of AIN457 versus p...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01090310
Purpose of the study was to demonstrate the efficacy of secukinumab versus ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06-19
Trial ID
NCT01806597
Treatments Being Tested